Overview

Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants

Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that rhBSSL improves growth in preterm infants as compared with placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Swedish Orphan Biovitrum
Treatments:
Bile Acids and Salts